Hila Karah currently serves as Managing Partner at Pitango Healthtech since September 2022 and is a Board Member at Variantyx, Indaptus Therapeutics, Inc., and OncoHost. With an extensive background in leadership roles, Hila has been a Member of the Board of Directors at DarioHealth since November 2014 and served on the board of TillaCare Ltd., Intec Pharma Ltd., and MyHeritage until April 2021. Hila's previous positions include Executive Chairman at FloraFotonica and Chief Investment Officer at Eurotrust Ltd. Hila Karah is an alumnus of the University of California, Berkeley, and UC Berkeley/UCSF.
Links